Pages that link to "Q43734294"

The following pages link to Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression (Q43734294):

Displaying 50 items.

• Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation (Q24658452) (← links)
• SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms (Q26749468) (← links)
• Combating pathogenic microorganisms using plant-derived antimicrobials: a minireview of the mechanistic basis (Q26851551) (← links)
• Interspecies communication in the gut, from bacterial delivery to host‐cell response (Q27012975) (← links)
• Interactions between the microbiota and pathogenic bacteria in the gut (Q28080209) (← links)
• Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications (Q28384349) (← links)
• The Crosstalk between the Gut Microbiota and Mitochondria during Exercise (Q33705451) (← links)
• Dynamics of the microbiota in response to host infection (Q33889891) (← links)
• The gut microbiota: challenging immunology (Q34003510) (← links)
• Altering host resistance to infections through microbial transplantation (Q34064885) (← links)
• Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis (Q34584247) (← links)
• SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens (Q34945452) (← links)
• Guanylate cyclase C limits systemic dissemination of a murine enteric pathogen. (Q34978181) (← links)
• Citrobacter rodentium: infection, inflammation and the microbiota (Q35218043) (← links)
• Cancer and the microbiome: potential applications as new tumor biomarker (Q35508820) (← links)
• The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor (Q35533302) (← links)
• Redox biology of the intestine (Q35534376) (← links)
• Maternal exposure to fish oil primes offspring to harbor intestinal pathobionts associated with altered immune cell balance. (Q35537907) (← links)
• The interplay between microbiome dynamics and pathogen dynamics in a murine model ofClostridium difficileInfection (Q35577842) (← links)
• Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. (Q35611711) (← links)
• Transmissible microbial and metabolomic remodeling by soluble dietary fiber improves metabolic homeostasis (Q35651768) (← links)
• Space Environmental Factor Impacts upon Murine Colon Microbiota and Mucosal Homeostasis. (Q35665962) (← links)
• Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella (Q35689478) (← links)
• Vitamin A-Deficient Hosts Become Nonsymptomatic Reservoirs of Escherichia coli-Like Enteric Infections (Q35745512) (← links)
• Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. (Q35745963) (← links)
• Frenemies: Signaling and Nutritional Integration in Pathogen-Microbiota-Host Interactions (Q35768800) (← links)
• Intestinal redox biology and oxidative stress (Q36095043) (← links)
• Citrobacter rodentium mouse model of bacterial infection (Q36126306) (← links)
• Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease (Q36250322) (← links)
• Diet-microbiota interactions and their implications for healthy living (Q36607673) (← links)
• White button mushrooms increase microbial diversity and accelerate the resolution of Citrobacter rodentium infection in mice. (Q37082311) (← links)
• Innate host responses to enteric bacterial pathogens: a balancing act between resistance and tolerance. (Q37974695) (← links)
• The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? (Q38049252) (← links)
• The application of Ussing chambers for determining the impact of microbes and probiotics on intestinal ion transport (Q38132251) (← links)
• Optimising gut colonisation resistance against Clostridium difficile infection. (Q38583798) (← links)
• The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease (Q38661453) (← links)
• Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium (Q39384143) (← links)
• Helminth-induced alterations of the gut microbiota exacerbate bacterial colitis (Q40274577) (← links)
• Dietary Lipid Type, Rather Than Total Number of Calories, Alters Outcomes of Enteric Infection in Mice. (Q40719394) (← links)
• Human Gut Microbiota: Toward an Ecology of Disease (Q41024163) (← links)
• Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection (Q41823445) (← links)
• Removal of the cecum affects intestinal fermentation, enteric bacterial community structure, and acute colitis in mice. (Q46244021) (← links)
• Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment (Q46262570) (← links)
• Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis (Q46267786) (← links)
• Citrobacter rodentium Relies on Commensals for Colonization of the Colonic Mucosa. (Q47126570) (← links)
• The bacterial virulence factor CagA induces microbial dysbiosis that contributes to excessive epithelial cell proliferation in the Drosophila gut. (Q47156406) (← links)
• Analysis of Gut Microbiome and Diet Modification in Patients with Crohn's Disease. (Q55279616) (← links)
• Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice (Q57112601) (← links)
• The tyrosine phosphatase Shp-2 confers resistance to colonic inflammation by driving goblet cell function and crypt regeneration (Q58096686) (← links)
• Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli (Q59794078) (← links)